Smith Christine A M, Toupin-April Karine, Jutai Jeffrey W, Duffy Ciarán M, Rahman Prinon, Cavallo Sabrina, Brosseau Lucie
School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada; Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
PLoS One. 2015 Sep 10;10(9):e0137180. doi: 10.1371/journal.pone.0137180. eCollection 2015.
The objectives of this review are to: 1) appraise the methodological quality of clinical practice guidelines (CPGs) in juvenile idiopathic arthritis (JIA) providing pharmacological and/or non-pharmacological intervention recommendations, and 2) summarize the recommendations provided by the included CPGs and compare them where possible.
A systematic search was performed. Three trained appraisers independently evaluated the methodological quality of the CPGs using a validated and reliable instrument, the Appraisal of Guidelines in Research and Evaluation II. Six domains were considered: 1) score and purpose; 2) stakeholder involvement; 3) rigor of development; 4) clarity of presentation; 5) applicability; and 6) editorial independence. The domains consist of a total of 23 items each scored on a 7-point scale. High quality CPGs were identified if they had a domain score above 60% in rigor of development, and two other domains.
Of the three included CPGs, the Royal Australian College of General Practitioners (RACGP) and American College of Rheumatology (ACR) CPGs were considered to be of high quality, but the German Society for Pediatric Rheumatology was of lower quality. Domains one to four had high domain scores across the guidelines (mean (standard deviation)): 72.76 (13.80); 66.67 (9.81); 64.67 (7.77); and 87.00 (9.64), respectively. Lower scores were obtained for applicability (14.00 (5.57)) and editorial independence (43.44 (7.02)). Recommendations varied across CPGs due to differences in context, target audience (general practitioners, rheumatologists, and other multidisciplinary healthcare professionals) and patients' disease presentations. Despite this variability, progression of pharmacological treatment did not conflict between CPGs. Recommendations for non-pharmacological interventions were vague and the interventions considered varied between CPGs.
Overall, recommendations were based on a paucity of evidence and weak study designs. Further research is needed on interventions in JIA, as well as higher quality CPGs to facilitate implementation of the best evidence-based recommendations in clinical practice.
本综述的目的是:1)评估为青少年特发性关节炎(JIA)提供药物和/或非药物干预建议的临床实践指南(CPG)的方法学质量;2)总结纳入的CPG提供的建议,并在可能的情况下进行比较。
进行了系统检索。三名经过培训的评估人员使用经过验证且可靠的工具《研究与评估指南II》独立评估CPG的方法学质量。考虑了六个领域:1)评分与目的;2)利益相关者参与;3)制定的严谨性;4)表述的清晰度;5)适用性;6)编辑独立性。每个领域共有23项,每项按7分制评分。如果CPG在制定的严谨性方面的领域得分高于60%,且在其他两个领域得分也较高,则被认定为高质量CPG。
在纳入的三个CPG中,澳大利亚皇家全科医生学院(RACGP)和美国风湿病学会(ACR)的CPG被认为质量较高,但德国儿科风湿病学会的CPG质量较低。指南中领域一至四的领域得分较高(均值(标准差)):分别为72.76(13.80);66.67(9.81);64.67(7.77);87.00(9.64)。适用性(14.00(5.57))和编辑独立性(43.44(7.02))得分较低。由于背景、目标受众(全科医生、风湿病学家和其他多学科医疗保健专业人员)以及患者疾病表现的差异,不同CPG的建议各不相同。尽管存在这种差异,但CPG之间在药物治疗进展方面并无冲突。非药物干预的建议较为模糊,且不同CPG考虑的干预措施也有所不同。
总体而言,建议基于证据不足和研究设计薄弱。需要对JIA的干预措施以及更高质量的CPG进行进一步研究,以促进在临床实践中实施最佳的循证建议。